weight loss surgery vs glp-1 Metabolic and agonists | Blog How Medical Weight Loss Methods

In weight management, the slower microdose pathway prioritizes sustained adherence and comfort over speed, recognizing that many patients abandon therapy due to nausea or vomiting rather than lack of efficacy

Transitions in either direction are common

In concert, these results define a new scenario of action for incretin-based therapy that may involve the adipo-insular axis, linking the weight lowering competence with the sustained protection of -cells from diabetogenic stressors

This change only applies to weight loss drugs (e.g., GLP-1 and non-GLP-1 drugs) when they are prescribed solely for weight loss and not for any other medical conditions that the FDA has approved them for, the company said in a statement

Deng, G

[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Zinman B., Aroda V.R., Buse J.B., Cariou B., Harris S.B., Hoff S.T